Supernus Pharmaceuticals Inc (SUPN)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 661,817 | 607,521 | 673,056 | 560,079 | 500,962 |
| Total assets | US$ in thousands | 1,368,070 | 1,277,670 | 1,702,510 | 1,689,150 | 1,504,100 |
| Total asset turnover | 0.48 | 0.48 | 0.40 | 0.33 | 0.33 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $661,817K ÷ $1,368,070K
= 0.48
Supernus Pharmaceuticals Inc has shown a consistent total asset turnover ratio of around 0.33 in both December 31, 2020 and December 31, 2021. This indicates that for every dollar of total assets the company holds, it generates $0.33 in revenue.
There has been a notable increase in total asset turnover from 0.33 in December 31, 2021 to 0.40 in December 31, 2022, which suggests the company is becoming more efficient in generating sales from its assets.
Furthermore, the total asset turnover ratio continued to improve to 0.48 by December 31, 2023 and remained at the same level in December 31, 2024. This demonstrates the company's ability to utilize its assets more effectively to drive revenue growth over time.
Overall, the trend in Supernus Pharmaceuticals Inc's total asset turnover indicates a gradual improvement in the company's efficiency in generating sales from its total asset base, which is a positive sign for its financial performance.
Peer comparison
Dec 31, 2024